Evidence map›Paper›PMID 19726230›Full record

ReviewTrends in molecular medicine2009

Protein S-nitrosylation in health and disease: a current perspective.

Matthew W Foster, Douglas T Hess, Jonathan S Stamler

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Trends in molecular medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03926741 (Methods to Identify and Treat Severe Asthma Patients Project 1), which is not on this map. Cited by 375 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
375citing papers in PubMed, 1 pooled it
36.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03926741 early_phase1completednot on this mapstarted 2019, after this paper: background citation

Methods to Identify and Treat Severe Asthma Patients Project 1: GSNOR Phenotyping and GSNO Challenge

TypeinterventionalSponsorJames ReynoldsRan2019 to 2024Enrolled48ConditionsAsthmaArmsGSNO Challenge
3 · Its place in the literature

Who cites it

375 citing papers in PubMed, 1 synthesis or guideline pooled it, 736 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Gold Nanoparticles Coated With the Antimicrobial Peptide Os-C(W5): Anticandidal and Biological Activity.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  4. Article
  5. Intracellular Crosstalk of the Gasotransmitter Trio (NO, CO, HInternational journal of molecular sciences · 2026
    Review
  6. Sex differences in mitochondrial CaJournal of molecular and cellular cardiology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Dysregulated ProteinCirculation research · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Profiling the landscape of cysteine posttranslational modifications in brain aging and neurodegeneration.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  19. Thermogenic Adipose ADH5 Counteracts Age-related Metabolic Decline.bioRxiv : the preprint server for biology · 2025
    Article
  20. Modulation of Redox-Sensitive Cardiac Ion Channels.Antioxidants (Basel, Switzerland) · 2025
    Review

315 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Matthew W FosterDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Douglas T Hess
Jonathan S Stamler
Duke University Hospital · USDuke Medical Center · US

Funding

Regulation of Beta-Adrenergic Receptor Signaling by S-NitrosylationP01HL075443 · NHLBI · DUKE UNIVERSITY · PI STAMLER, JONATHAN S. · 2004 to 2019
$26.1M
The Pathogenesis and Genetics of Environmental AsthmaU19ES012496 · NIEHS · DUKE UNIVERSITY · PI FOSTER, WILLIAM MICHAEL · 2004 to 2007
$6.4M
Redox Signalling by Nitric Oxide in Skeletal MuscleR01HL059130 · NHLBI · DUKE UNIVERSITY · PI STAMLER, JONATHAN S. · 1997 to 2011
$3.1M
Red Blood Cell S-nitrosothiols and OxygenationR01HL091876 · NHLBI · DUKE UNIVERSITY · PI STAMLER, JONATHAN S. · 2009 to 2012
$1.6M
NO HEMOGLOBIN INTERACTION IN THE PULMONARY VASCULATURER01HL066179 · NHLBI · DUKE UNIVERSITY · PI STAMLER, JONATHAN S. · 2001 to 2001
$305k
NHLBI NIH HHS HL059130NHLBI NIH HHS HL075443NHLBI NIH HHS P01 HL075443NHLBI NIH HHS R01 HL059130NHLBI NIH HHS R01 HL066179NHLBI NIH HHS R01 HL091876NIEHS NIH HHS U19 ES012496NIEHS NIH HHS U19-ES012496
6 · The paper itself

Abstract

Protein S-nitrosylation constitutes a large part of the ubiquitous influence of nitric oxide on cellular signal transduction and accumulating evidence indicates important roles for S-nitrosylation both in normal physiology and in a broad spectrum of human diseases. Here we review recent findings that implicate S-nitrosylation in cardiovascular, pulmonary, musculoskeletal and neurological (dys)function, as well as in cancer. The emerging picture shows that, in many cases, pathophysiology correlates with hypo- or hyper-S-nitrosylation of specific protein targets rather than a general cellular insult due to loss of or enhanced nitric oxide synthase activity. In addition, it is increasingly evident that dysregulated S-nitrosylation can not only result from alterations in the expression, compartmentalization and/or activity of nitric oxide synthases, but can also reflect a contribution from denitrosylases, including prominently the S-nitrosoglutathione (GSNO)-metabolizing enzyme GSNO reductase. Finally, because exogenous mediators of protein S-nitrosylation or denitrosylation can substantially affect the development or progression of disease, potential therapeutic agents that modulate S-nitrosylation could well have broad clinical utility.

Indexed as

HealthAnimalsDiseaseHumansNitratesNitric OxideNitrosationProteinsSignal TransductionNitratesNitric OxideProteins

Identifiers

PMID19726230
PMCPMC3106339
OpenAlexW2014433643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.